# Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL

> **NCT02080234** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 40 (estimated)

## Conditions studied

- Lymphoma, Extranodal NK-T-Cell

## Interventions

- **DRUG:** GELOX
- **RADIATION:** IFRT

## Key facts

- **NCT ID:** NCT02080234
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-12
- **Final completion:** 2017-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02080234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02080234, "Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02080234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*